Theravance Biopharma (TBPH) Invested Capital (2018 - 2022)
Theravance Biopharma's Invested Capital came in at $46.32 million for Q2 2022, down 43.3% from $81.64 million a year earlier but up 11.0% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Invested Capital (2018 - 2022) Analysis & Trends
For FY2021, Theravance Biopharma's Invested Capital was $49.73 million, down 43.8% from FY2020.
- Invested Capital carries a three-year compound annual growth rate of -34.6% (FY2018 to FY2021).
- Going back by year, Invested Capital was $88.46 million in FY2020, $5.31 million in FY2019 (-97.0%) and $177.95 million in FY2018.
- The five-year range for quarterly Invested Capital is $5.31 million (Q4 2019) to $215.92 million (Q1 2020).
- Year-over-year, Invested Capital increased in two of the last seven quarters, with growth averaging 11.7%.
- The fastest year-over-year change in Invested Capital over five years came in Q1 2022 (growth of 206.3%), and the weakest in Q4 2019 (a decline of 97.0%).
- Business Quant data shows TBPH's Invested Capital at $41.72 million (Q1 2022), $49.73 million (Q4 2021) and $64.51 million (Q3 2021) in the three quarters before Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 46.32 Mn |
| Mar 31, 2022 | 41.72 Mn |
| Dec 31, 2021 | 49.73 Mn |
| Sep 30, 2021 | 64.51 Mn |
| Jun 30, 2021 | 81.64 Mn |
| Mar 31, 2021 | 13.62 Mn |
| Dec 31, 2020 | 88.46 Mn |
| Sep 30, 2020 | 122.95 Mn |
| Jun 30, 2020 | 172.93 Mn |
| Mar 31, 2020 | 215.92 Mn |
| Dec 31, 2019 | 5.31 Mn |
| Sep 30, 2019 | 47.90 Mn |
| Jun 30, 2019 | 92.84 Mn |
| Mar 31, 2019 | 116.45 Mn |
| Dec 31, 2018 | 177.95 Mn |
API Access
Theravance Biopharma Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();